首页> 外文OA文献 >A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial
【2h】

A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial

机译:患者为期贬低的复合患者对多酚疾病的贬低干预:理论和设计的棚栽医学随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Background Polypharmacy is prevalent among hospitalized older adults, particularly those being discharged to a post-care care facility (PAC). The aim of this randomized controlled trial is to determine if a patient-centered deprescribing intervention initiated in the hospital and continued in the PAC setting reduces the total number of medications among older patients. Methods The Shed-MEDS study is a 5-year, randomized controlled clinical intervention trial comparing a patient-centered describing intervention with usual care among older (≥50 years) hospitalized patients discharged to PAC, either a skilled nursing facility (SNF) or an inpatient rehabilitation facility (IPR). Patient measurements occur at hospital enrollment, hospital discharge, within 7 days of PAC discharge, and at 60 and 90 days following PAC discharge. Patients are randomized in a permuted block fashion, with block sizes of two to four. The overall effectiveness of the intervention will be evaluated using total medication count as the primary outcome measure. We estimate that 576 patients will enroll in the study. Following attrition due to death or loss to follow-up, 420 patients will contribute measurements at 90 days, which provides 90% power to detect a 30% versus 25% reduction in total medications with an alpha error of 0.05. Secondary outcomes include the number of medications associated with geriatric syndromes, drug burden index, medication adherence, the prevalence and severity of geriatric syndromes and functional health status. Discussion The Shed-MEDS trial aims to test the hypothesis that a patient-centered deprescribing intervention initiated in the hospital and continuing through the PAC stay will reduce the total number of medications 90 days following PAC discharge and result in improvements in geriatric syndromes and functional health status. The results of this trial will quantify the health outcomes associated with reducing medications for hospitalized older adults with polypharmacy who are discharged to post-acute care facilities. Trial registration This trial was prospectively registered at clinicaltrials.gov (NCT02979353). The trial was first registered on 12/1/2016, with an update on 09/28/17 and 10/12/2018.
机译:摘要背景多野营普遍存在的住院老年人,特别是那些被排放到护理后保健设施(PAC)的人。该随机对照试验的目的是确定在医院中启动的患者中心剥夺干预,并在PAC环境中继续降低老年患者的药物总数。方法棚栽医学研究是一个5年,随机对照临床干预试验,比较患者以患者为中心的描述干预,在较老的(≥50年)住院患者往返于PAC,熟练的护理设施(SNF)或一个住院性康复设施(IPR)。患者测量发生在医院注册,医院放电,在PAC放电7天内,在PAC放电后60和90天。患者以允许的块方式随机化,块尺寸为2至四个。将使用总用药计数作为主要结果措施来评估干预的总体效果。我们估计576名患者将参加该研究。由于死亡或随访丧失的消耗,420名患者将在90天内有贡献测量,为90%的功率检测30%的动力,与α误差为0.05的总药物减少25%。二次结果包括与老年人综合征,药物负担指数,药物依恋,老年综合征和功能健康状况的患病率和严重程度相关的药物数量。讨论Shed-Meds试验旨在测试在医院中发起的患者中心贬低干预,并继续通过PAC留下的假设将减少PAC排放后90天的药物总数,并导致Gerirtic综合征和功能健康的改善地位。该试验的结果将量化与减少住院老年人的药物有关的健康结果,这些成年人与急性护理设施出院的多酚省期。试验登记此试验在ClinicalTrials.gov(NCT02979353)上进行了潜在注册。该试验首次于12月1日在2016年12月12日注册,于09/28/17和10/12/2018更新。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号